APRI (Aprinoia Therapeutics) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2023)


What is Aprinoia Therapeutics Other Stockholders Equity?

Aprinoia Therapeutics APRI Other Stockholders Equity is $-0.00 Mil as of Dec. 2023.

Aprinoia Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was $-0.00 Mil.

Aprinoia Therapeutics's quarterly Other Stockholders Equity declined from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($-0.00 Mil) but then stayed the same from Jun. 2023 ($-0.00 Mil) to Dec. 2023 ($-0.00 Mil).

Aprinoia Therapeutics's annual Other Stockholders Equity increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil) but then declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($-0.00 Mil).

Aprinoia Therapeutics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Other Stockholders Equity Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Other Stockholders Equity
-0.00 0.00 -0.00

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity -0.00 0.00 0.00 -0.00 -0.00

Aprinoia Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Aprinoia Therapeutics (APRI) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Other Stockholders Equity too high?
Aprinoia Therapeutics' current Other Stockholders Equity is $-0.00 Mil.
How does Aprinoia Therapeutics' Other Stockholders Equity compare to ?
Aprinoia Therapeutics' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.